{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:53:21Z","timestamp":1791453201119,"version":"4.3.3"},"reference-count":213,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.cca.2018.05.046","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T13:15:58Z","timestamp":1527167758000},"page":"150-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":442,"special_numbering":"C","title":["Uric acid and cardiovascular disease"],"prefix":"10.1016","volume":"484","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8725-055X","authenticated-orcid":false,"given":"Gjin","family":"Ndrepepa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.cca.2018.05.046_bb0005","article-title":"A concise history of gout and hyperuricemia and their treatment","volume":"8","author":"Nuki","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2018.05.046_bb0010","first-page":"73","article-title":"Examen chemicum calculi urinarii [A chemical examination of kidney stones]","volume":"2","author":"Scheele","year":"1776","journal-title":"Opuscula"},{"key":"10.1016\/j.cca.2018.05.046_bb0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1098\/rstl.1798.0004","article-title":"Experiments and observations, tending to show the composition and properties of urinary concretions","volume":"88","author":"Pearson","year":"1798","journal-title":"Phil. Trans. R. Soc. London"},{"key":"10.1016\/j.cca.2018.05.046_bb0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jlac.18751750116","article-title":"Zur Constitution der Harns\u00e4uregruppe","volume":"175","author":"Medicus","year":"1875","journal-title":"Justus Liebigs Ann. Chem"},{"key":"10.1016\/j.cca.2018.05.046_bb0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/cber.189703001110","article-title":"Ueber die Constitution des Caffeins, Xanthins, Hypoxanthins und Verwandter Basen","volume":"30","author":"Fischer","year":"1897","journal-title":"Ber. Dtsch. Chem. Ges."},{"key":"10.1016\/j.cca.2018.05.046_bb0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cber.18990320171","article-title":"Synthesen in der Puringruppe","volume":"32","author":"Fischer","year":"1899","journal-title":"Ber. Dtsch. Chem. Ges."},{"key":"10.1016\/j.cca.2018.05.046_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/095952874803100109","article-title":"Observations on certain pathological conditions of the blood and urine in gout, rheumatism and Bright's disease","volume":"31","author":"Garrod","year":"1848","journal-title":"Trans. Med. Chir. Soc. Edinb."},{"key":"10.1016\/j.cca.2018.05.046_bb0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(02)45936-3","article-title":"On Bright's disease, and its essential symptoms","volume":"1","author":"Mohamed","year":"1879","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2018.05.046_bb0045","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/bmj.1.1467.288","article-title":"On uric acid and arterial tension","volume":"1","author":"Haig","year":"1889","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2018.05.046_bb0050","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.7326\/0003-4819-34-6-1421","article-title":"Serum uric acid in relation to age and physique in health and in coronary heart disease","volume":"34","author":"Gertler","year":"1951","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2105\/AJPH.41.3.279","article-title":"Epidemiological approaches to heart disease: the Framingham study","volume":"41","author":"Dawber","year":"1951","journal-title":"Am. J. Public Health Nation Health"},{"key":"10.1016\/j.cca.2018.05.046_bb0060","first-page":"611","article-title":"The coronary profile: 12-year follow-up in the Framingham study","volume":"9","author":"Kannel","year":"1967","journal-title":"J. Occup. Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0065","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/bj2350747","article-title":"Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid","volume":"235","author":"Davies","year":"1986","journal-title":"Biochem. J."},{"key":"10.1016\/j.cca.2018.05.046_bb0070","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1113\/jphysiol.2003.055913","article-title":"Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications","volume":"555","author":"Berry","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0075","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.atherosclerosis.2014.10.006","article-title":"Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress","volume":"237","author":"Battelli","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2018.05.046_bb0080","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.bbadis.2014.05.022","article-title":"Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme","volume":"1842","author":"Battelli","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2018.05.046_bb0085","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and nutrition examination survey 2007-2008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2018.05.046_bb0090","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res.(Hoboken)"},{"key":"10.1016\/j.cca.2018.05.046_bb0095","first-page":"1295","article-title":"Is it time to revise the normal range of serum uric acid levels?","volume":"18","author":"Desideri","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cca.2018.05.046_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1515\/cclm-2015-0523","article-title":"Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis","volume":"54","author":"Braga","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00360-008-0291-7","article-title":"Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society?","volume":"179","author":"Johnson","year":"2009","journal-title":"J. Comp. Physiol. B."},{"key":"10.1016\/j.cca.2018.05.046_bb0115","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.12659\/MSM.899852","article-title":"Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview","volume":"22","author":"Chen","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.cca.2018.05.046_bb0120","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/oxfordjournals.molbev.a004123","article-title":"Loss of urate oxidase activity in hominoids and its evolutionary implications","volume":"19","author":"Oda","year":"2002","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.cca.2018.05.046_bb0125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00163854","article-title":"Two independent mutational events in the loss of urate oxidase during hominoid evolution","volume":"34","author":"Wu","year":"1992","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.cca.2018.05.046_bb0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00269094","article-title":"Immunohistochemical localization of xanthine oxidase in human cardiac and skeletal muscle","volume":"100","author":"Hellsten-Westing","year":"1993","journal-title":"Histochemistry"},{"key":"10.1016\/j.cca.2018.05.046_bb0135","first-page":"755","article-title":"Xanthine oxidoreductase and xanthine oxidase in human cornea","volume":"17","author":"Cejkova","year":"2002","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.cca.2018.05.046_bb0140","first-page":"967","article-title":"Cellular expression of xanthine oxidoreductase protein in normal human tissues","volume":"79","author":"Linder","year":"1999","journal-title":"Lab. Investig."},{"key":"10.1016\/j.cca.2018.05.046_bb0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000355405","article-title":"Uric acid - key ingredient in the recipe for cardiorenal metabolic syndrome","volume":"3","author":"Chaudhary","year":"2013","journal-title":"Cardiorenal Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0150","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa035700","article-title":"Purine-rich foods, dairy and protein intake, and the risk of gout in men","volume":"350","author":"Choi","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1471-2369-14-164","article-title":"The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality","volume":"14","author":"Gustafsson","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.cca.2018.05.046_bb0160","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/BF02506750","article-title":"\u00dcber das Verhalten der Kuhmilch gegen Methyleneblau und seine Verwendung zur Unterscheidung von ungekochter und gekochter Milch","volume":"5","author":"Schardinger","year":"1902","journal-title":"Z Untersuch Nahrungs Genussmittel"},{"key":"10.1016\/j.cca.2018.05.046_bb0165","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1111\/j.1742-4658.2008.06489.x","article-title":"Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase","volume":"275","author":"Nishino","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.cca.2018.05.046_bb0170","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1074\/jbc.272.13.8370","article-title":"The reaction of reduced xanthine dehydrogenase with molecular oxygen reaction kinetics and measurement of superoxide radical","volume":"272","author":"Harris","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2018.05.046_bb0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-5793(98)01686-X","article-title":"Irreversible conversion of xanthine dehydrogenase into xanthine oxidase by a mitochondrial protease","volume":"443","author":"Saksela","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cca.2018.05.046_bb0180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.redox.2013.05.002","article-title":"Xanthine oxidoreductase-catalyzed reactive species generation: a process in critical need of reevaluation","volume":"1","author":"Cantu-Medellin","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.cca.2018.05.046_bb0185","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/oxfordjournals.jbchem.a022669","article-title":"Sequence motif-specific assignment of two [2Fe-2S] clusters in rat xanthine oxidoreductase studied by site-directed mutagenesis","volume":"127","author":"Iwasaki","year":"2000","journal-title":"J. Biochem."},{"key":"10.1016\/j.cca.2018.05.046_bb0190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/abbi.1996.9844","article-title":"Xanthine oxidase binding to glycosaminoglycans: kinetics and superoxide dismutase interactions of immobilized xanthine oxidase-heparin complexes","volume":"339","author":"Radi","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cca.2018.05.046_bb0195","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1074\/jbc.275.8.5918","article-title":"Repressed expression of the human xanthine oxidoreductase gene E-box and TATA-like elements restrict ground state transcriptional activity","volume":"275","author":"Xu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2018.05.046_bb0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cbpa.2006.01.034","article-title":"Molybdenum and tungsten enzymes: the xanthine oxidase family","volume":"10","author":"Brondino","year":"2006","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.cca.2018.05.046_bb0205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11926-010-0093-2","article-title":"New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond","volume":"12","author":"Schlesinger","year":"2010","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.cca.2018.05.046_bb0210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2018.05.046_bb0215","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11906-006-0007-x","article-title":"Uric acid: its relationship to renal hemodynamics and the renal renin-angiotensin system","volume":"8","author":"Zhou","year":"2006","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.cca.2018.05.046_bb0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5527\/wjn.v2.i2.17","article-title":"Uric acid and chronic kidney disease: a time to act?","volume":"2","author":"Bellomo","year":"2013","journal-title":"World J. Nephrol."},{"key":"10.1016\/j.cca.2018.05.046_bb0225","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI42344","article-title":"Uric acid transport and disease","volume":"120","author":"So","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2018.05.046_bb0230","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.ackd.2012.07.009","article-title":"Renal transport of uric acid: evolving concepts and uncertainties","volume":"19","author":"Bobulescu","year":"2012","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.cca.2018.05.046_bb0235","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1080\/13880209.2016.1195847","article-title":"Uric acid transporters hiding in the intestine","volume":"54","author":"Xu","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.cca.2018.05.046_bb0240","doi-asserted-by":"crossref","first-page":"16229","DOI":"10.1074\/jbc.M312226200","article-title":"Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking","volume":"279","author":"Augustin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2018.05.046_bb0245","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cellbi.2004.11.024","article-title":"Expression of the GLUT1 and GLUT9 facilitative glucose transporters in embryonic chondroblasts and mature chondrocytes in ovine articular cartilage","volume":"29","author":"Mobasheri","year":"2005","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.cca.2018.05.046_bb0250","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.ASN.0000107560.80107.19","article-title":"Function and localization of urate transporter 1 in mouse kidney","volume":"15","author":"Hosoyamada","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2018.05.046_bb0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng.2500","article-title":"Genome-wide association analyses identify 18 new loci associated with serum urate concentrations","volume":"45","author":"Kottgen","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cca.2018.05.046_bb0260","doi-asserted-by":"crossref","first-page":"e1000504","DOI":"10.1371\/journal.pgen.1000504","article-title":"Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations","volume":"5","author":"Kolz","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.cca.2018.05.046_bb0265","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCGENETICS.109.934455","article-title":"Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors","volume":"3","author":"Yang","year":"2010","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.cca.2018.05.046_bb0270","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.amjmed.2011.11.010","article-title":"Nature versus nurture in gout: a twin study","volume":"125","author":"Krishnan","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030456","article-title":"Extra-renal elimination of uric acid via intestinal efflux transporter BCRP\/ABCG2","volume":"7","author":"Hosomi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2018.05.046_bb0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10157-013-0806-8","article-title":"Uric acid transporter ABCG2 is increased in the intestine of the 5\/6 nephrectomy rat model of chronic kidney disease","volume":"18","author":"Yano","year":"2014","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.cca.2018.05.046_bb0285","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2018.05.046_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/srep31003","article-title":"Hyperuricemia in acute gastroenteritis is caused by decreased urate excretion via ABCG2","volume":"6","author":"Matsuo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2018.05.046_bb0295","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0300","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1073\/pnas.1320393111","article-title":"Evolutionary history and metabolic insights of ancient mammalian uricases","volume":"111","author":"Kratzer","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2018.05.046_bb0305","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1042\/bj1620601","article-title":"The mechanism of adenosine triphosphate depletion in the liver after a load of fructose. A kinetic study of liver adenylate deaminase","volume":"162","author":"van den Berghe","year":"1977","journal-title":"Biochem. J."},{"key":"10.1016\/j.cca.2018.05.046_bb0310","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/er.2008-0033","article-title":"Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?","volume":"30","author":"Johnson","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2018.05.046_bb0315","doi-asserted-by":"crossref","first-page":"F625","DOI":"10.1152\/ajprenal.00140.2005","article-title":"A causal role for uric acid in fructose-induced metabolic syndrome","volume":"290","author":"Nakagawa","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0320","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bbagen.2016.11.042","article-title":"Fructose suppresses uric acid excretion to the intestinal lumen as a result of the induction of oxidative stress by NADPH oxidase activation","volume":"1861","author":"Kaneko","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2018.05.046_bb0325","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.2174\/138161205774913255","article-title":"Uric acid and oxidative stress","volume":"11","author":"Glantzounis","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cca.2018.05.046_bb0330","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/qjmed\/hcr159","article-title":"Is there anything good in uric acid?","volume":"104","author":"Alvarez-Lario","year":"2011","journal-title":"QJM"},{"key":"10.1016\/j.cca.2018.05.046_bb0335","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/228868a0","article-title":"Similar functions of uric acid and ascorbate in man?","volume":"228","author":"Proctor","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.cca.2018.05.046_bb0340","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2018.05.046_bb0345","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/jmg.18.6.410","article-title":"Genes for super-intelligence?","volume":"18","author":"Sofaer","year":"1981","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.cca.2018.05.046_bb0350","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.HYP.0000028589.66335.AA","article-title":"Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity","volume":"40","author":"Watanabe","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2018.05.046_bb0355","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1468-1331.2002.00384.x","article-title":"Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction","volume":"9","author":"Toncev","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cca.2018.05.046_bb0360","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/rheumatology\/keq095","article-title":"Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: a cross-sectional study","volume":"49","author":"Kuo","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2018.05.046_bb0365","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000170883","article-title":"Plasma urate and progression of mild cognitive impairment","volume":"6","author":"Irizarry","year":"2009","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.cca.2018.05.046_bb0370","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that alerts the immune system to dying cells","volume":"425","author":"Shi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cca.2018.05.046_bb0375","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cca.2018.05.046_bb0380","first-page":"1582","article-title":"Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population","volume":"31","author":"Wallace","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cca.2018.05.046_bb0385","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","article-title":"Gout epidemiology: results from the UK general practice research database, 1990-1999","volume":"64","author":"Mikuls","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2018.05.046_bb0390","article-title":"Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2018.05.046_bb0395","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and nutrition examination survey","volume":"283","author":"Fang","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2018.05.046_bb0400","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2796.2009.02133.x","article-title":"Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the apolipoprotein MOrtality RISk study (AMORIS)","volume":"266","author":"Holme","year":"2009","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0405","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/ATVBAHA.107.160184","article-title":"Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA\/KORA cohort study","volume":"28","author":"Meisinger","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2018.05.046_bb0410","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.164.14.1546","article-title":"Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study","volume":"164","author":"Niskanen","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0415","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.STR.0000221716.55088.d4","article-title":"Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study","volume":"37","author":"Bos","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2018.05.046_bb0420","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study","volume":"131","author":"Culleton","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020076","article-title":"Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis","volume":"2","author":"Wheeler","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0430","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/2047487313519346","article-title":"Uric acid and cardiovascular disease risk reclassification: findings from NHANES III","volume":"22","author":"Zalawadiya","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0435","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24164","article-title":"Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study","volume":"61","author":"Chen","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2018.05.046_bb0440","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijcard.2011.06.055","article-title":"Hyperuricemia and increased risk of ischemic heart disease in a large Chinese cohort","volume":"154","author":"Chuang","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0445","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1373\/clinchem.2007.094425","article-title":"Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men","volume":"54","author":"Strasak","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2018.05.046_bb0450","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijcard.2007.11.094","article-title":"Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study","volume":"125","author":"Strasak","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0455","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2261-13-115","article-title":"Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from the Tromso study","volume":"13","author":"Storhaug","year":"2013","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.cca.2018.05.046_bb0460","first-page":"7","article-title":"U-shaped association between serum uric acid levels with cardiovascular and all-cause mortality in the elderly: the role of malnourishment","author":"Tseng","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cca.2018.05.046_bb0465","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/01.ATV.0000161274.87407.26","article-title":"Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals","volume":"25","author":"Ishizaka","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2018.05.046_bb0470","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3899\/jrheum.080646","article-title":"Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute family heart study","volume":"36","author":"Neogi","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cca.2018.05.046_bb0475","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1530\/EJE-08-0618","article-title":"Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children","volume":"160","author":"Pacifico","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2018.05.046_bb0480","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.atherosclerosis.2007.03.008","article-title":"Uric acid level and its association with carotid intima-media thickness in patients with hypertension","volume":"197","author":"Tavil","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2018.05.046_bb0485","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/joim.12120","article-title":"Longitudinal association between serum urate and subclinical atherosclerosis: the coronary artery risk development in young adults (CARDIA) study","volume":"274","author":"Wang","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0490","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/jch.12313","article-title":"Serum uric acid is associated with coronary artery calcification","volume":"16","author":"Grossman","year":"2014","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.cca.2018.05.046_bb0495","article-title":"Asymptomatic hyperuricemia is independently associated with coronary artery calcification in the absence of overt coronary artery disease: a single-center cross-sectional study","volume":"96","author":"Kim","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cca.2018.05.046_bb0500","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3899\/jrheum.100639","article-title":"Serum urate is not associated with coronary artery calcification: the NHLBI family heart study","volume":"38","author":"Neogi","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cca.2018.05.046_bb0505","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.amjcard.2013.12.022","article-title":"Relation of serum uric acid to severity and progression of coronary artery calcium in postmenopausal white and Filipino women (from the Rancho Bernardo study)","volume":"113","author":"Calvo","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0510","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","article-title":"Hyperuricemia and coronary heart disease: a systematic review and meta-analysis","volume":"62","author":"Kim","year":"2010","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.cca.2018.05.046_bb0515","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2013.08.023","article-title":"Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies","volume":"231","author":"Zhao","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2018.05.046_bb0520","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2017-0487","article-title":"Hyperuricemia does not seem to be an independent risk factor for coronary heart disease","volume":"56","author":"Battaggia","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0525","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/art.24612","article-title":"Hyperuricemia and risk of stroke: a systematic review and meta-analysis","volume":"61","author":"Kim","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2018.05.046_bb0530","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jacc.2015.10.086","article-title":"Causal assessment of serum urate levels in Cardiometabolic diseases through a Mendelian randomization study","volume":"67","author":"Keenan","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0535","article-title":"Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies","volume":"357","author":"Li","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2018.05.046_bb0540","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/rheumatology\/kex065","article-title":"Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis","volume":"56","author":"Zhang","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2018.05.046_bb0545","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of Febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0550","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2710.1998.00125.x","article-title":"Serum uric acid levels in cardiovascular diseases","volume":"23","author":"Torun","year":"1998","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.cca.2018.05.046_bb0555","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/art.23121","article-title":"Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study","volume":"58","author":"Ioachimescu","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2018.05.046_bb0560","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9149(01)01621-6","article-title":"Identification of uric acid and xanthine oxidase in atherosclerotic plaque","volume":"88","author":"Patetsios","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0565","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.metabol.2012.05.014","article-title":"Association of uric acid with mortality in patients with stable coronary artery disease","volume":"61","author":"Ndrepepa","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2018.05.046_bb0570","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.numecd.2013.03.005","article-title":"A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease","volume":"23","author":"Ndrepepa","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.cca.2018.05.046_bb0575","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0002-9149(01)02155-5","article-title":"Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease","volume":"89","author":"Bickel","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0580","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1253\/circj.CJ-08-0828","article-title":"Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese coronary artery disease (JCAD) study","volume":"73","author":"Okura","year":"2009","journal-title":"Circ. J."},{"key":"10.1016\/j.cca.2018.05.046_bb0585","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1540-8183.2010.00555.x","article-title":"The association of serum uric acid levels with outcomes following percutaneous coronary intervention","volume":"23","author":"Spoon","year":"2010","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0590","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.numecd.2011.02.008","article-title":"Uric acid is predictive of cardiovascular mortality and sudden cardiac death in subjects referred for coronary angiography","volume":"23","author":"Silbernagel","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.cca.2018.05.046_bb0595","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/eci.12039","article-title":"Uric acid and prognosis in angiography-proven coronary artery disease","volume":"43","author":"Ndrepepa","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.cca.2018.05.046_bb0600","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2016.10.006","article-title":"Elevated serum uric acid and risk of cardiovascular or all-cause mortality in people with suspected or definite coronary artery disease: a meta-analysis","volume":"254","author":"Wang","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2018.05.046_bb0605","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.amjcard.2005.04.007","article-title":"Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese acute coronary syndrome study)","volume":"96","author":"Kojima","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0610","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijcard.2008.06.024","article-title":"Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers a single center experience","volume":"138","author":"Lazzeri","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0615","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11739-011-0515-9","article-title":"Uric acid in the early risk stratification of ST-elevation myocardial infarction","volume":"7","author":"Lazzeri","year":"2012","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0620","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.amjcard.2011.12.018","article-title":"Prognostic value of uric acid in patients with acute coronary syndromes","volume":"109","author":"Ndrepepa","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0625","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/MCA.0000000000000593","article-title":"The association between uric acid levels and different clinical manifestations of coronary artery disease","volume":"29","author":"Larsen","year":"2018","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.cca.2018.05.046_bb0630","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCHEARTFAILURE.108.797662","article-title":"Hyperuricemia and incident heart failure","volume":"2","author":"Krishnan","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.cca.2018.05.046_bb0635","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijcard.2009.01.010","article-title":"Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study","volume":"142","author":"Ekundayo","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0640","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.amjcard.2010.06.023","article-title":"Effect of serum insulin on the association between hyperuricemia and incident heart failure","volume":"106","author":"Desai","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0645","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijcard.2017.11.083","article-title":"Serum uric acid as a potential marker for heart failure risk in men on antihypertensive treatment: the British regional heart study","volume":"252","author":"Wannamethee","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0650","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1751-7133.2011.00200.x","article-title":"Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis","volume":"17","author":"Tamariz","year":"2011","journal-title":"Congestive Heart Fail."},{"key":"10.1016\/j.cca.2018.05.046_bb0655","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/eurjhf\/hft132","article-title":"Uric acid and risk of heart failure: a systematic review and meta-analysis","volume":"16","author":"Huang","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.cca.2018.05.046_bb0660","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1751-7133.2011.00259.x","article-title":"Hyperuricemia and the echocardiographic measures of myocardial dysfunction","volume":"18","author":"Krishnan","year":"2012","journal-title":"Congestive Heart Fail."},{"key":"10.1016\/j.cca.2018.05.046_bb0665","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1067\/mhj.2002.122122","article-title":"Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy","volume":"143","author":"Cicoira","year":"2002","journal-title":"Am. Heart J."},{"key":"10.1016\/j.cca.2018.05.046_bb0670","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1067\/mhj.2001.114367","article-title":"Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance","volume":"141","author":"Doehner","year":"2001","journal-title":"Am. Heart J."},{"key":"10.1016\/j.cca.2018.05.046_bb0675","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/oxfordjournals.eurheartj.a015352","article-title":"Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure","volume":"18","author":"Leyva","year":"1997","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2018.05.046_bb0680","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/hrt.2006.090845","article-title":"Increased levels of uric acid predict haemodynamic compromise in patients with heart failure independently of B-type natriuretic peptide levels","volume":"93","author":"Kittleson","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.cca.2018.05.046_bb0685","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2015.08.089","article-title":"Uric acid and xanthine oxidase in heart failure - emerging data and therapeutic implications","volume":"213","author":"Doehner","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0690","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1253\/circj.70.1006","article-title":"Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure","volume":"70","author":"Sakai","year":"2006","journal-title":"Circ. J."},{"key":"10.1016\/j.cca.2018.05.046_bb0695","first-page":"L830","article-title":"Xanthine oxidoreductase in respiratory and cardiovascular disorders","volume":"294","author":"Boueiz","year":"2008","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.cca.2018.05.046_bb0700","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/heartjnl-2012-302535","article-title":"The role of uric acid in the pathogenesis of human cardiovascular disease","volume":"99","author":"Kanbay","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.cca.2018.05.046_bb0705","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2015.08.110","article-title":"Relation of serum uric acid to cardiovascular disease","volume":"213","author":"Wu","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0710","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/HJH.0b013e3283569a9c","article-title":"An update on biomarkers of heart failure in hypertensive patients","volume":"30","author":"Gluba","year":"2012","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2018.05.046_bb0715","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.hrthm.2014.04.003","article-title":"Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis","volume":"11","author":"Tamariz","year":"2014","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.cca.2018.05.046_bb0720","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.CIR.103.5.750","article-title":"Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing-induced heart failure","volume":"103","author":"Ukai","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2018.05.046_bb0725","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2011.10.895","article-title":"Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts","volume":"59","author":"Hirsch","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0730","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cardfail.2006.05.005","article-title":"The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: la plata study","volume":"12","author":"Cingolani","year":"2006","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.cca.2018.05.046_bb0735","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000144303.24894.1C","article-title":"Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?","volume":"110","author":"Engberding","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2018.05.046_bb0740","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/01.CIR.0000017502.58595.ED","article-title":"Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies","volume":"105","author":"Doehner","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2018.05.046_bb0745","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.CIR.0000022140.61460.1D","article-title":"Allopurinol improves endothelial dysfunction in chronic heart failure","volume":"106","author":"Farquharson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2018.05.046_bb0750","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/hrt.2004.040477","article-title":"Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure","volume":"91","author":"Gavin","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.cca.2018.05.046_bb0755","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCHEARTFAILURE.109.868604","article-title":"Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study","volume":"3","author":"Ogino","year":"2010","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.cca.2018.05.046_bb0760","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","article-title":"High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid","volume":"114","author":"George","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2018.05.046_bb0765","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","article-title":"Impact of oxypurinol in patients with symptomatic heart failureResults of the OPT-CHF study","volume":"51","author":"Hare","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0770","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.114.014536","article-title":"Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study","volume":"131","author":"Givertz","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2018.05.046_bb0775","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000443769","article-title":"Hyperuricemia, cardiovascular disease, and hypertension","volume":"3","author":"Kuwabara","year":"2016","journal-title":"Pulse (Basel)"},{"key":"10.1016\/j.cca.2018.05.046_bb0780","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.HYP.0000085858.66548.59","article-title":"Hyperuricemia in childhood primary hypertension","volume":"42","author":"Feig","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2018.05.046_bb0785","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.111.183244","article-title":"Uric acid level and elevated blood pressure in US adolescents: national health and nutrition examination survey, 1999-2006","volume":"59","author":"Loeffler","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2018.05.046_bb0790","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3109\/10641969609081033","article-title":"Uric acid, xanthine oxidase and other risk factors of hypertension in normotensive subjects","volume":"18","author":"Newaz","year":"1996","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.cca.2018.05.046_bb0795","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1549-8719.1999.tb00100.x","article-title":"A mechanism of oxygen free radical production in the dahl hypertensive rat","volume":"6","author":"Swei","year":"1999","journal-title":"Microcirculation"},{"key":"10.1016\/j.cca.2018.05.046_bb0800","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1073\/pnas.95.8.4754","article-title":"Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats","volume":"95","author":"Suzuki","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2018.05.046_bb0805","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Mazzali","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2018.05.046_bb0810","doi-asserted-by":"crossref","first-page":"F1105","DOI":"10.1152\/ajprenal.00170.2002","article-title":"Mild hyperuricemia induces glomerular hypertension in normal rats","volume":"283","author":"Sanchez-Lozada","year":"2002","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0815","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2018.05.046_bb0820","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/HYPERTENSIONAHA.112.196980","article-title":"Uric acid reduction rectifies prehypertension in obese adolescents","volume":"60","author":"Soletsky","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2018.05.046_bb0825","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1751-7176.2012.00701.x","article-title":"Effect of allopurinol on blood pressure: a systematic review and meta-analysis","volume":"15","author":"Agarwal","year":"2013","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.cca.2018.05.046_bb0830","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008652.pub2","article-title":"Pharmacotherapy for hyperuricemia in hypertensive patients","volume":"1","author":"Gois","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cca.2018.05.046_bb0835","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00004872-200018080-00021","article-title":"Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)","volume":"18","author":"Franse","year":"2000","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2018.05.046_bb0840","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1523-1755.2004.00484.x","article-title":"The impact of serum uric acid on cardiovascular outcomes in the LIFE study","volume":"65","author":"Hoieggen","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2018.05.046_bb0845","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/ajh.2008.245","article-title":"Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients","volume":"21","author":"Hamada","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cca.2018.05.046_bb0850","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.amjcard.2011.06.043","article-title":"Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study)","volume":"108","author":"Tamariz","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0855","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.amjcard.2013.04.012","article-title":"Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus","volume":"112","author":"Valbusa","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0860","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1253\/circj.CJ-16-0766","article-title":"Uric acid level and prevalence of atrial fibrillation in a Japanese general population of 285,882","volume":"80","author":"Kawasoe","year":"2016","journal-title":"Circ. J."},{"key":"10.1016\/j.cca.2018.05.046_bb0865","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1536\/ihj.16-192","article-title":"Hyperuricemia and atrial fibrillation","volume":"57","author":"Maharani","year":"2016","journal-title":"Int. Heart J."},{"key":"10.1016\/j.cca.2018.05.046_bb0870","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/aje\/kws002","article-title":"Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study","volume":"176","author":"Krishnan","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0875","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2014.04.080","article-title":"High uric acid directly inhibits insulin signalling and induces insulin resistance","volume":"447","author":"Zhu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2018.05.046_bb0880","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/CIRCULATIONAHA.106.657627","article-title":"Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents","volume":"115","author":"Ford","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2018.05.046_bb0885","doi-asserted-by":"crossref","first-page":"E71","DOI":"10.1002\/oby.20061","article-title":"Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults","volume":"21","author":"Mangge","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.cca.2018.05.046_bb0890","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2036.2011.04788.x","article-title":"Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease","volume":"34","author":"Petta","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.cca.2018.05.046_bb0895","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.HYP.0000210550.97398.c2","article-title":"Serum uric acid is associated with microalbuminuria in prehypertension","volume":"47","author":"Lee","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2018.05.046_bb0900","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1291\/hypres.24.691","article-title":"Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects","volume":"24","author":"Iseki","year":"2001","journal-title":"Hypertens. Res."},{"issue":"Pt 1","key":"10.1016\/j.cca.2018.05.046_bb0905","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/bj3400143","article-title":"When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid","volume":"340","author":"Bagnati","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.cca.2018.05.046_bb0910","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1194\/jlr.M200407-JLR200","article-title":"Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid","volume":"44","author":"Patterson","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2018.05.046_bb0915","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/15257770902736400","article-title":"Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress","volume":"28","author":"Gersch","year":"2009","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.cca.2018.05.046_bb0920","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.freeradbiomed.2010.04.010","article-title":"Radicals in the reaction between peroxynitrite and uric acid identified by electron spin resonance spectroscopy and liquid chromatography mass spectrometry","volume":"49","author":"Imaram","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2018.05.046_bb0925","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bcp.2005.05.009","article-title":"Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase","volume":"70","author":"Kuzkaya","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cca.2018.05.046_bb0930","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-7075-1-10","article-title":"Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle","volume":"1","author":"Hayden","year":"2004","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.cca.2018.05.046_bb0935","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/15257770802257952","article-title":"Inactivation of nitric oxide by uric acid","volume":"27","author":"Gersch","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.cca.2018.05.046_bb0940","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","article-title":"Hyperuricemia induces endothelial dysfunction","volume":"67","author":"Khosla","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2018.05.046_bb0945","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1096\/fj.13-247148","article-title":"Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis","volume":"28","author":"Choi","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.cca.2018.05.046_bb0950","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.cellbio.16.1.145","article-title":"Molecular regulation of adipogenesis","volume":"16","author":"Rosen","year":"2000","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.cca.2018.05.046_bb0955","doi-asserted-by":"crossref","first-page":"C1183","DOI":"10.1152\/ajpcell.00075.2008","article-title":"Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells","volume":"295","author":"Zharikov","year":"2008","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.cca.2018.05.046_bb0960","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jjcc.2012.01.013","article-title":"Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications","volume":"59","author":"Puddu","year":"2012","journal-title":"J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb0965","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/eurheartj\/ehi879","article-title":"Uric acid and inflammatory markers","volume":"27","author":"Ruggiero","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2018.05.046_bb0970","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019901","article-title":"Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study","volume":"6","author":"Lyngdoh","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2018.05.046_bb0975","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?","volume":"41","author":"Johnson","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2018.05.046_bb0980","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000103377","article-title":"The endogenous danger signal uric acid augments contact hypersensitivity responses in mice","volume":"74","author":"Liu","year":"2007","journal-title":"Pathobiology"},{"key":"10.1016\/j.cca.2018.05.046_bb0985","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/HJH.0b013e328337da1d","article-title":"Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction","volume":"28","author":"Yu","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2018.05.046_bb0990","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1523-1755.2004.00909.x","article-title":"Uric acid and the state of the intrarenal renin-angiotensin system in humans","volume":"66","author":"Perlstein","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2018.05.046_bb0995","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1532-5415.1978.tb02396.x","article-title":"Serum uric acid and the renin-angiotensin system in hypertension","volume":"26","author":"Saito","year":"1978","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.cca.2018.05.046_bb1000","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/HJH.0b013e328303205d","article-title":"Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency","volume":"26","author":"Eraranta","year":"2008","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2018.05.046_bb1005","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2215\/CJN.10771016","article-title":"Effect of uric acid lowering on renin-angiotensin-system activation and ambulatory BP: a randomized controlled trial","volume":"12","author":"McMullan","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2018.05.046_bb1010","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1745-7254.2008.00877.x","article-title":"Uric acid stimulates endothelin-1 gene expression associated with NADPH oxidase in human aortic smooth muscle cells","volume":"29","author":"Chao","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cca.2018.05.046_bb1015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijcard.2008.09.004","article-title":"Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts","volume":"139","author":"Cheng","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb1020","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","article-title":"A role for uric acid in the progression of renal disease","volume":"13","author":"Kang","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2018.05.046_bb1025","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1681\/ASN.2006030264","article-title":"Human vascular smooth muscle cells express a urate transporter","volume":"17","author":"Price","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2018.05.046_bb1030","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1016\/S0021-9258(18)93017-6","article-title":"Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression","volume":"266","author":"Rao","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2018.05.046_bb1035","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","article-title":"Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2","volume":"41","author":"Kanellis","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2018.05.046_bb1040","doi-asserted-by":"crossref","first-page":"C584","DOI":"10.1152\/ajpcell.00600.2006","article-title":"Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative\/nitrosative stress","volume":"293","author":"Sautin","year":"2007","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.cca.2018.05.046_bb1045","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0026-0495(99)90163-4","article-title":"Serum leptin is associated with serum uric acid concentrations in humans","volume":"48","author":"Fruehwald-Schultes","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2018.05.046_bb1050","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1096\/fj.13-243634","article-title":"Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids","volume":"28","author":"Cicerchi","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.cca.2018.05.046_bb1055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mce.2013.04.027","article-title":"Uric acid induces oxidative stress and growth inhibition by activating adenosine monophosphate-activated protein kinase and extracellular signal-regulated kinase signal pathways in pancreatic beta cells","volume":"375","author":"Zhang","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cca.2018.05.046_bb1060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jacc.2015.09.109","article-title":"Genetic causality in complex traits: the case of uric acid","volume":"67","author":"Marian","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2018.05.046_bb1065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MCA.0000000000000600","article-title":"Elevated serum uric acid \u2013 a marker and mediator of increased stress on myocardium","volume":"29","author":"Ndrepepa","year":"2018","journal-title":"Coron. Artery Dis."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811830264X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811830264X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T19:54:28Z","timestamp":1720295668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989811830264X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":213,"alternative-id":["S000989811830264X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2018.05.046","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uric acid and cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2018.05.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}